Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 20 Oct, 01:00 am

Piper Sandler has lowered its price target for First Financial Bankshares (NASDAQ: FFIN) to $33.00 from $35.00 . The company reported mixed third-quarter 2026 results, with revenue of $177.77 million slightly missing estimates by 0.65% , while EPS of $0.52 met expectations. First

Venture Global's Strategic Expansion: The company is actively expanding its power business , securing deals with key partners and planning natural gas-fired power plants to serve data centers . Market Performance Outlook: Bernstein has issued a "Market Perform" rating for Venture

Fifth Third Bancorp (NYSE: FITB) Q3 Earnings: Adjusted EPS Beats Estimates Fifth Third Bancorp reported third-quarter 2026 GAAP diluted earnings of $0.90 per share and adjusted earnings of $1.13 per share , exceeding the Zacks consensus estimate of $1.09. Revenue on a fully taxab

Fox Factory (NASDAQ: FOXF) shares experienced a significant decline, leading Roth Capital to maintain a Neutral rating. The company revised its 2026 net sales outlook downwards due to various operational challenges. Fox Factory announced a leadership change, appointing an interim

Adjusted earnings per share (EPS) of $0.28 surpassed analyst estimates of $0.21 . Quarterly revenue reached $5.61 billion , falling short of the $5.69 billion estimate. Cleveland-Cliffs shares surged 14% following an optimistic outlook for 2027, bolstered by tariffs. Cleveland-Cl

JetBlue Airways (NASDAQ: JBLU) Stock: UBS Upgrade Amid Price Decline and Analyst Revisions UBS upgraded JetBlue Airways (NASDAQ: JBLU) from Sell to Neutral while lowering its price target from $4.00 to $3.50 . TD Cowen and Seaport Research Partners also revised their outlooks, re

Bernstein analyst Peter Weed has set a $350.00 price target for Datadog (NASDAQ: DDOG) , suggesting a potential gain of approximately 41.6% . The cloud software company reported strong fiscal second-quarter results, including $1.12 billion in revenue and a 23% operating margin .

Piper Sandler downgraded Boston Properties (NYSE: BXP) from Overweight to Neutral, setting a $64 price target. Boston Properties sold a 10.6% equity interest in its 343 Madison Avenue development to AVRS Partners. The 343 Madison Avenue office tower, with an estimated $2 billion

Earnings Beat, Revenue Miss: Citizens Financial Group (NYSE:CFG) reported earnings per share of $1.41 , surpassing estimates of $1.39 , despite revenue of $2.322 billion falling short of the $2.339 billion estimate. Profit Growth: Despite the revenue miss, GAAP net income increas

Analyst Nathan Jones of Stifel Nicolaus downgraded LCI Industries (NYSE: LCII) from Buy to Hold, setting an $80.00 price target. The recreational vehicle (RV) and marine parts supplier's stock is trading near its 52-week low of $77.58 , with a current market capitalization of app

A. O. Smith (NYSE: AOS) Faces Market Challenges Despite Growth Outlook and Dividend Increase Stifel downgraded A. O. Smith (NYSE: AOS) from Buy to Hold and cut its price target to $59 from $70. A. O. Smith expects 2026 sales to grow 2%–3%, supported by its boiler, water tre

Jefferies has issued a "Buy" rating for Raia Drogasil (OTCQX: RADLY) , a prominent Brazilian pharmacy retailer, despite recent share price drops. The company's latest quarterly earnings per share of $0.05 met analyst expectations, though its revenue of $2.17 billion fell short of

Jefferies has increased its price target for Cenovus Energy (NYSE: CVE) to C$54.00 , maintaining a Buy rating. Cenovus is strategically expanding its oil and gas production through acquisitions, including MEG Energy and a planned cash-and-stock deal for Athabasca Oil. The company

Spyre Therapeutics (NASDAQ: SYRE) Presents IBD Data, Earns UBS Buy Rating Spyre Therapeutics (NASDAQ: SYRE) is developing long-acting antibody treatments for inflammatory bowel disease (IBD) . The company presented clinical data for SPY001, SPY002 and SPY003 from its Phase 2 SKYL

Mixed Q2 Fiscal 2027 Performance: HDFC Bank (NYSE: HDB) reported revenue of $13.4 billion , surpassing estimates, but its earnings per share (EPS) of $0.39 fell slightly below the $0.40 forecast. Optimistic Outlook for Net Interest Margin: Management anticipates an improvement in

Bombardier is investing approximately $50 million to expand its Wichita, Kansas, operations, focusing on technician training and aircraft service capabilities. The investment includes the establishment of a new North American Learning Center and an expansion of the Wichita Wheel

Jefferies has increased its price target for Murphy Oil, though the stock currently trades above this new target. Recent oil discoveries in Vietnam and successful appraisal results in Côte d’Ivoire are providing positive momentum for the energy sector company. Key production proj

Recent biotech IPOs Iambic Therapeutics (NASDAQ: IAM) and City Therapeutics (NASDAQ: CTY) posted strong gains. Inverse leveraged ETFs SMCZ and SMST advanced as their underlying stocks declined. Iambic Therapeutics (NASDAQ: IAM) advanced 25.9% to $23.81. The company recently sold
Headlines provided by Investing.com